Search all trials

Find therapies in clinical trials near you – page 8

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Immune thrombocytopenia

Recruiting

InvestigationalNo placebo

A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years

Contact Research Centre

Dementia with Lewy bodies

Recruiting

Investigational

A Study Testing ACP-204 Tartrate Compared to Placebo for Adults with Lewy Body Dementia Psychosis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Acp-204 Tartrate

Contact Research Centre

Immune thrombocytopenia

Recruiting

Investigational

A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

Investigational

Bulgaria

Participants:18–64 years · 65+ years

Contact Research Centre

Graves' disease

Recruiting

Investigational

Study of IMVT-1402 Treatment for Adults with Graves' Disease

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:IMEROPRUBART

Contact Research Centre

Breast cancer+2

Recruiting

Registered drugNo placebo

Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Colitis ulcerative+1

Recruiting

Registered drugNo placebo

Long-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn's disease

Registered drugNo placebo

Bulgaria

Participants:0–17 years
Substances:Vedolizumab

Contact Research Centre

Systemic scleroderma+3

Recruiting

Registered drugNo placebo

Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Arteriosclerosis

Recruiting

InvestigationalNo placebo

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Pelacarsen

Contact Research Centre

Major depression

Recruiting

InvestigationalNo placebo

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Contact Research Centre

Transitional cell cancer of the renal pelvis and ureter

Recruiting

InvestigationalNo placebo

Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Mitomycin

Contact Research Centre

Atrial fibrillation

Recruiting

Investigational

Study of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:AP31969 SULFATE

Contact Research Centre

Varicella

Recruiting

Registered drugNo placebo

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Registered drugNo placebo

Bulgaria

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896

Contact Research Centre

Find therapies in clinical trials near you – page 8

436 trials match your criteria

Immune thrombocytopenia

A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness

Dementia with Lewy bodies

A Study Testing ACP-204 Tartrate Compared to Placebo for Adults with Lewy Body Dementia Psychosis

Immune thrombocytopenia

A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

Graves' disease

Study of IMVT-1402 Treatment for Adults with Graves' Disease

Breast cancer+2

Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

Colitis ulcerative+1

Long-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn's disease

Systemic scleroderma+3

Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease

Arteriosclerosis

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

Major depression

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

Transitional cell cancer of the renal pelvis and ureter

Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

Atrial fibrillation

Study of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation

Varicella

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.